Trauma-Informed Intervention for Procedural Pain
(TIPPI-R Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on managing pain and distress during cancer treatment, so it's best to discuss your medications with the trial team.
What data supports the effectiveness of the treatment TIPPI-R for procedural pain?
Is the Trauma-Informed Intervention for Procedural Pain (TIPPI-R) generally safe for humans?
How does the TIPPI-R treatment differ from other treatments for procedural pain?
TIPPI-R is unique because it incorporates trauma-informed care principles, focusing on understanding and addressing the emotional and psychological needs of patients who have experienced trauma. This approach is different from traditional treatments that primarily focus on physical pain management, as it aims to create a supportive environment that promotes safety, trust, and empowerment for the patient.1112131415
What is the purpose of this trial?
The Trauma-Informed Procedural Pain Intervention (TIPPI-R) has been developed as a standardized way to provide education and teach evidence-based strategies for managing pain and distress that may occur during pediatric cancer treatment. The purpose of this clinical trial study is to test how helpful TIPPI-R is in supporting children and families manage pain and distress during the initial stages of cancer treatment. The main questions this study aims to answer are:* Does TIPPI-R increase use of helpful pain coping strategies for pediatric cancer patients?* Does TIPPI-R help lower perceived pain intensity during initial stages of cancer treatment?* Does TIPPI-R increase patient and family confidence in coping with pain and distress during cancer treatment?Researchers will compare pain experiences and use of pain coping strategies for families who receive the TIPPI-R intervention and families who receive standard of care to see if TIPPI-R decrease pain and distress during the initial stages of cancer treatment.Participants will:* Complete surveys to measure pain and distress within 5 weeks of initial diagnosis (Time 1)* Either receive the TIPPI-R intervention or standard of care* Complete surveys to measure pain and distress 4 weeks after initial consent or TIPPI-R intervention delivery (Time 2)
Research Team
Lauren R Hayes, PhD
Principal Investigator
Norton Children's Medical Group, Affiliated with the University of Louisville School of Medicine
Eligibility Criteria
This trial is for children with cancer experiencing pain during treatment. Participants must be within the first 5 weeks of their initial diagnosis and able to complete surveys. There's no mention of specific exclusion criteria, so it seems open to those meeting the inclusion terms.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Assessment
Participants complete surveys to measure pain and distress within 5 weeks of initial diagnosis
Intervention
Participants receive either the TIPPI-R intervention or standard of care
Follow-up
Participants complete surveys to measure pain and distress 4 weeks after initial consent or TIPPI-R intervention delivery
Treatment Details
Interventions
- TIPPI-R
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Louisville
Lead Sponsor
University of Kentucky
Collaborator
Kentucky Cabinet for Health and Family Services
Collaborator
Norton Healthcare
Collaborator